Personalized recombinant Idiotype vaccination after chemotherapy as initial treatment for mantle cell lymphoma.

被引：0
|
作者：
Leonard, J
Vose, J
Timmerman, J
Levy, R
Ingolia, D
Denney, D
Coleman, M
Kunkel, L
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY USA
[2] New York Presbyterian Hosp, New York, NY USA
[3] Univ Nebraska, Med Ctr, Omaha, NE USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[5] Genitope Corp, Redwood City, CA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4792
引用
收藏
页码：312B / 312B
页数：1
相关论文
共 50 条
  • [1] Recombinant idiotype-KLH vaccination (MyVaXTM) following CHOP chemotherapy in mantle cell lymphoma.
    Leonard, JP
    Vose, J
    Timmerman, J
    Levy, R
    Coleman, M
    King, S
    Ingolia, D
    Denney, D
    BLOOD, 2003, 102 (11) : 105A - 105A
  • [2] Immune response to Idiotype vaccination following high dose chemotherapy plus autologous stem cell transplant in indolent and mantle cell lymphoma.
    Holman, P
    Bashey, A
    Carrier, E
    Corringham, S
    Davis, B
    Oblon, DJ
    Chen, R
    Gold, D
    Mu, X
    Ball, ED
    BLOOD, 2002, 100 (11) : 315B - 315B
  • [3] Cladribine plus rituximab for the initial treatment of mantle cell lymphoma.
    Pindyck, T.
    Spurgeon, S. E.
    Okada, C. Y.
    Epner, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Idiotype vaccine following EPOCH-rituximab treatment in untreated mantle cell lymphoma.
    Wilson, WH
    Neelapu, S
    White, T
    Hegde, U
    Pittaluga, S
    Hakim, F
    Stetler-Stevenson, M
    Frye, R
    Steinberg, S
    Jaffe, ES
    Gress, R
    Staudt, L
    Janik, J
    Kwak, L
    BLOOD, 2002, 100 (11) : 162A - 162A
  • [5] Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma
    Timmerman, John M.
    Vose, Julie M.
    Czerwinski, Debra K.
    Weng, Wen-Kai
    Ingolia, Diane
    Mayo, Martha
    Denney, Dan W.
    Levy, Ronald
    LEUKEMIA & LYMPHOMA, 2009, 50 (01) : 37 - 46
  • [6] Mantle cell lymphoma.
    Densmore J.J.
    Williams M.E.
    Current Treatment Options in Oncology, 2000, 1 (3) : 281 - 285
  • [7] A total approach to the treatment of advanced mantle cell lymphoma.
    Lim, SH
    Esler, WV
    Beggs, D
    Zhang, Y
    Wang, ZQ
    Smith, P
    Burris, C
    Townsend, M
    BLOOD, 2003, 102 (11) : 286B - 286B
  • [8] Dendritic cell-based therapy for the treatment of mantle cell lymphoma.
    Munger, CM
    Hentzen, A
    Vose, JM
    Bociek, RG
    Joshi, SS
    BLOOD, 2003, 102 (11) : 106A - 106A
  • [9] TREATMENT OF RELAPSING OR REFRACTORY MANTLE CELL LYMPHOMA. UNICENTRIC STUDY
    Marc, Sorigue
    Juan-Manuel, Sancho
    Lluis, Virgili
    Miriam, Moreno
    Cristina, Motllo
    Gustavo, Tapia
    Susanna, Gassiot
    Alberto, Pineda
    Jose-Luis, Mate
    Laura, Abril
    Monica, Linares
    Clara, Maluquer
    Edurne, Sarrate
    Ana, Triguero
    Neus, Ruiz-Xiville
    Anna, Torrent
    Susana, Vives
    Christelle, Ferra
    Blanca, Xicoy
    Montserrat, Batlle
    Gladys, Ibarra
    Immaculada, Portal
    Jose-Tomas, Navarro
    Evarist, Feliu
    Josep-Maria, Ribera
    HAEMATOLOGICA, 2016, 101 : 207 - 208
  • [10] The changing face of mantle cell lymphoma.
    Goepel, JR
    Lorigan, PC
    Vandenberghe, EA
    Allen, JE
    Hammond, DW
    Hancock, BW
    BRITISH JOURNAL OF CANCER, 1998, 78 : 5 - 5
12345